InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Discover the complete record of transactions filed by Serber Zachariah, Directeur Scientifique. Insider active across 1 companies, notably Zymergen Inc.. In total, 12 reports have been published. Total volume traded: €320k. The latest transaction was disclosed on 2 June 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
€4,3882,812 shares@ €1.56041.4% of flow
Common Stock
SEC:0001645842-22-000098:0·
€5,2503,082 shares@ €1.70361.6% of flow
Common Stock
SEC:0001645842-22-000063:0·
0208,000 shares0
Common Stock
SEC:0001645842-22-000034:0·
€14,0194,011 shares@ €3.49514.4% of flow
Common Stock
SEC:0001645842-22-000023:0·
€4,9231,424 shares@ €3.45721.5% of flow
Common Stock
SEC:0001645842-22-000021:0·
€19,1205,435 shares@ €3.51796.0% of flow
Common Stock
SEC:0001645842-22-000017:0·
€20,5405,435 shares@ €3.779215.1% of flow
Common Stock
SEC:0001645842-22-000015·
€20,5405,435 shares@ €3.77926.4% of flow
Common Stock
SEC:0001645842-22-000015:0·
€24,5325,435 shares@ €4.513718.0% of flow
Common Stock
SEC:0001645842-22-000011·
€24,5325,435 shares@ €4.51377.7% of flow
Common Stock
SEC:0001645842-22-000011:0·
€91,21021,730 shares@ €4.197466.9% of flow
Common Stock
SEC:0001645842-22-000009·
€91,21021,730 shares@ €4.197428.5% of flow
Common Stock
SEC:0001645842-22-000009:0·
12 of 12 declarations
About Serber Zachariah
Zachariah Serber is the Chief Science Officer at Zymergen Inc. In this role, he oversees the company's research and development initiatives, which focus on innovation in biotechnology. With expertise in the sciences, he plays a crucial role in the research strategy of Zymergen Inc.
